| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2023 | MRMD Marimed Inc. | Shaw Timothy | Chief Operating Officer | Sell | 33,272 | $0.32 | $10,680.31 | -0.4% | - | - | |
| Oct 26, 2023 | VTRS Viatris Inc | Korman Harry48 | Director | Buy | 4,403 | $13.91 | $61,252.14 | +0.5% | +30.4% | +27.3% | |
| Oct 19, 2023 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $225.43 | $1,352,591.23 | -3.8% | -1.6% | +63.2% | |
| Oct 19, 2023 | ANIP Ani Pharmaceuticals Inc | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 25,000 | $57.75 | $1,443,868.50 | -0.8% | -3.0% | +5.2% | |
| Oct 18, 2023 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 923 | $172.92 | $159,605.16 | -3.8% | +13.8% | +12.7% | |
| Oct 16, 2023 | BSPK Bespoke Extracts, Inc. | Feinsod Michael | CEO | Buy | 3,000 | $0.20 | $599.70 | +0.1% | - | - | |
| Oct 16, 2023 | EOLS Evolus, Inc. | Medytox Inc. | Former 10% Owner | Sell | 1,690,663 | $7.50 | $12,679,972.50 | -33.3% | +25.7% | +101.2% | |
| Oct 16, 2023 | ANIP Ani Pharmaceuticals Inc | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 25,000 | $57.96 | $1,449,035.99 | -1.2% | -5.4% | +0.0% | |
| Oct 13, 2023 | DERM Journey Medical Corp | Smith Justin Adam | Director | Buy | 33,000 | $2.98 | $98,340.00 | +46.0% | +66.2% | +95.0% | |
| Oct 11, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 215,000 | $605.44 | $130,169,878.97 | - | +3.3% | +50.5% | |
| Oct 10, 2023 | DVAX Dynavax Technologies Corp | Janssen Robert71 | SVP And CMO | Sell | 1,755 | $15.01 | $26,342.55 | -3.4% | -4.8% | -27.9% | |
| Oct 6, 2023 | DERM Journey Medical Corp | Paley Jeffrey59 | Director | Buy | 15,000 | $2.98 | $44,700.00 | +26.1% | +72.0% | +126.0% | |
| Oct 5, 2023 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $223.82 | $1,342,922.80 | -3.7% | -0.0% | +55.9% | |
| Oct 5, 2023 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 9,133 | $6.23 | $56,906.81 | -2.2% | +43.4% | +179.9% | |
| Oct 4, 2023 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 18,266 | $6.25 | $114,208.17 | -2.1% | +55.5% | +176.3% | |
| Oct 3, 2023 | EGRX Eagle Pharmaceuticals, Inc. | Tarriff Scott | CEO | Sell | 20,245 | $14.82 | $300,026.47 | -1.2% | - | - | |
| Oct 2, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $45.78 | $22,889.55 | -0.6% | +36.2% | +5.7% | |
| Oct 2, 2023 | ANIP Ani Pharmaceuticals Inc | Gassert Chad60 | SVP - Corp. Dev. &Strategy | Sell | 20,000 | $56.48 | $1,129,600.00 | -6.4% | +0.6% | +4.6% | |
| Oct 2, 2023 | DVAX Dynavax Technologies Corp | Janssen Robert71 | SVP And CMO | Sell | 5,015 | $15.03 | $75,375.45 | -9.1% | -4.0% | -24.6% | |
| Oct 2, 2023 | DVAX Dynavax Technologies Corp | Novack David F73 | President &COO | Sell | 40,000 | $14.88 | $595,000.00 | -60.3% | -4.0% | -24.6% | |
| Oct 2, 2023 | NBIX Neurocrine Biosciences Inc | Boyer David W.51 | Chief Corp. Affairs Officer | Sell | 1,437 | $112.68 | $161,921.16 | -22.7% | +17.8% | +2.1% | |
| Sep 28, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 75,000 | $2.04 | $153,307.50 | - | - | - | |
| Sep 27, 2023 | CBSTF Cannabist Co Holdings Inc. | Watson Derek | Chief Financial Officer | Buy | 5,000 | $1.00 | $5,000.00 | +4.7% | - | - | |
| Sep 25, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 30,000 | $2.08 | $62,286.00 | - | - | - | |
| Sep 22, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 10,000 | $2.10 | $21,000.00 | - | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.